期刊文献+

答复读者来信:布地奈德是“速效”药吗 被引量:1

原文传递
导出
摘要 首先感谢徐凤玲医生对本稿的关注及来信,下面逐条回答您的问题。1.支气管哮喘(简称哮喘)的治疗主要包括两部分:(1)非急性发作期采用控制药物进行长期控制治疗;(2)急性发作期采用缓解药物以缓解急性发作。吸入糖皮质激素(ICS)是首选的哮喘长期控制药物,用于儿童哮喘长期控制治疗时,全球哮喘防治创议(GINA)推荐的ICS剂量为100—400μg/d布地奈德或等效价的其他类型ICS,该剂量范围既可接近ICS的最大效应又可避免明显的全身性不良反应。
作者 陈爱欢
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2013年第8期640-640,共1页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献5

  • 1Global strategy for asthma management and prevention, Global Initiative for Asthma (GINA). 2011 [ http//www, ginasthma. org].
  • 2Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma : an evidence-based evaluation. Chest, 2006, 130 : 1301- 1311.
  • 3Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pesiatric asthma. Allergy, 2012,67 : 976- 997.
  • 4申昆玲,李云珠,李昌崇,刘恩梅,陈育智,陈志敏,俞善昌,洪建国,赵德育,盛锦云,鲍一笑.糖皮质激素雾化吸入疗法在儿科应用的专家共识[J].临床儿科杂志,2011,29(1):86-91. 被引量:236
  • 5中华医学会儿科学分会呼吸学组,中华医学会《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与治疗指南.中华儿科杂志,2008,46:745-753.

二级参考文献35

  • 1张远清,何颜霞,林荣枢.普米克令舒雾化吸入治疗小儿气管插管导致的喉头水肿[J].实用医学杂志,2006,22(23):2787-2788. 被引量:13
  • 2Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2008)[EB/OL].[2010-11-04] http://www.ginasthma.org/download.asp?intld=343.
  • 3Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2009)[EB/OL].[2010-11-04] http://www.ginasthma.com/download.asp?intld = 411.
  • 4洪建国.吸入装置的研究进展[M] //林江涛,殷凯生.哮喘防治新进展专题笔谈.北京:人民卫生出版社,2008:206-216.
  • 5Sbirlea-Apiou G,Katz I,Caillibotte G,et al.Deposition mechanics of pharmaceulical particles in human airways[M] //Hickey AJ.Inhalation Aerosols.New York:Informa Healthcare USA,2007:1-30.
  • 6Hess DR.Nebulizers:principles and performance[J].Respir Care,2000,45(6):609-622.
  • 7Dolovich MB,Ahrens RC,Hess DR,et al.Device selection and outcomes of aerosol therapy:evidence-based guidelines:American College of Chest Physicians/American College of Asthma,Allergy,and Immunology[J].Chest,2005.127(1):335-371.
  • 8Song IH,Buttgereit F.Non-genomic glucocorticoid effects to provide the basis for new drug developments[J].Mol Cell Endocrinol,2006,246(1-2):142-146.
  • 9Nuhoglu Y,Atas E,Nuhoglu C,et al.Acute effect of nebulized budesonide in asthmatic children[J].J Investig Allergol Clin Immunol,2005,15(3):197-200.
  • 10Desai D,Brightling C.Cough due to asthma,cough variant asthma and non-asthmatic eosinophilic bronchitis[J].Otolaryngol Clin North Am,2010,43(1):123-130.

共引文献235

同被引文献20

  • 1高改兰,张小斌,王凤洋,李维娜,高小宁.沐舒坦治疗新生儿重症肺炎58例疗效观察[J].中国儿童保健杂志,2007,15(2):204-205. 被引量:15
  • 2于红,吴结苟,田春.盐酸氨溴索的临床应用及哲学思考[J].攀枝花学院学报,2007,24(3):100-102. 被引量:8
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 4国家药品不良反应监测中心.药品不良反应信息通报:第49期:警惕盐酸氨溴索注射剂的严重过敏反应[EB/OL].(2012-09-03)[2014-12-18].http://www.sda.gov.cn/WS01/CL0078/74641.html.
  • 5Brozek JL,Bousquet J,Baena-Cagnani CE,et al.Allergic rhinitis and its impact on asthma(ARIA)guidelines:2010revision[J].J Allergy Clin Immunol,2010,126:466.
  • 6Turato G,Barbato A,Baraldo S,et al.Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma[J].Am J Respir Crit Care Med,2008,178:476.
  • 7Schuh S,Reisman J,Alshehri M,et al.A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma[J].N Engl J Med,2000,343:689.
  • 8Berger WE,White MV,Rhinitis Study Group.Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine[J].Ann Allergy Asthma Immunol,2003,91:205.
  • 9罗玉鸿,王嘉琳.2005-2007年我院呼吸系统药物用药分析[J].中国医药导报,2008,5(20):135-136. 被引量:2
  • 10马玲,李华斌.《变应性鼻炎及其对哮喘的影响》指南2010年修订版解读[J].中国耳鼻咽喉头颈外科,2011,18(1):47-53. 被引量:9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部